Luliconazole is a topical imidazole antifungal agent, specifically a novel imidazole derivative, used for the treatment of superficial dermatophytosis (tinea infections). It is characterized by its potent and broad-spectrum antifungal activity, particularly against Trichophyton species, which are the most common causative agents of tinea corporis, cruris, and pedis in India. Its 1% w/v formulation is available as cream, lotion, and solution for topical application.
Adult: Apply a thin layer to cover the affected area and surrounding skin once daily.
Note: Wash and dry the affected area thoroughly before application. Apply a thin film and rub gently. Wash hands after application unless hands are the treated area. For tinea pedis, apply between toes and on soles. Treatment duration: Tinea corporis/cruris: 1 week. Tinea pedis: 2 weeks. Pityriasis versicolor: 2 weeks. Continue for the full prescribed duration.
Luliconazole inhibits the biosynthesis of ergosterol, an essential component of the fungal cell membrane. It specifically inhibits the enzyme lanosterol 14α-demethylase, which is a cytochrome P-450 dependent enzyme. This inhibition leads to the accumulation of methylated sterol precursors and a depletion of ergosterol, resulting in increased membrane permeability, disruption of membrane-bound enzyme activity, and ultimately fungal cell death.
Pregnancy: Category B2 (Australian Category). Animal studies have shown no direct harm to the fetus, but there are no adequate and well-controlled studies in pregnant women. Use only if clearly needed and the potential benefit justifies the potential risk to the fetus, considering the minimal systemic absorption.
Driving: No effect on ability to drive or use machines.
| Other topical medications (e.g., corticosteroids, retinoids) | Potential for increased irritation or altered absorption. Space application by at least 1-2 hours. | Moderate |
| Systemic Azole Antifungals (e.g., Fluconazole, Itraconazole) | Theoretical additive effect, but clinically significant interaction unlikely due to topical route. | Low |